Literature DB >> 17147457

Restoring confidence in vaccines by explaining vaccine safety monitoring: is a targeted approach needed?

Rachel E Casiday1, Anthony R Cox.   

Abstract

Public trust in childhood vaccines is crucial to achieving adequate immunisation coverage to ensure population-level immunity. However, in the UK, immunisation uptake has been adversely affected by vaccine safety scares, such as those surrounding whooping cough and measles, mumps and rubella (MMR). It is our belief that greater public awareness of safety surveillance schemes may play a key role in improving trust in vaccine safety. Many parents of vaccination-age children are unaware of the procedures in place for postmarketing surveillance of vaccines. Thus, we propose specific steps for generating such awareness, such as assisting parents to report suspected adverse reactions directly to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card scheme, providing information about adverse reaction reporting with vaccination information packs, and displaying posters and leaflets to convey the message that patient concerns and experiences are taken seriously by the MHRA and to generate further awareness about the scheme. In addition, healthcare staff should be encouraged to report suspected adverse reactions relating to vaccine products. Unresolved issues about the scientific usefulness of data reported by parents and the potential for these steps to increase parental concern and expectations require further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147457     DOI: 10.2165/00002018-200629120-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  15 in total

1.  MMR vaccine: the continuing saga.

Authors:  D Elliman; H Bedford
Journal:  BMJ       Date:  2001-01-27

2.  Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.

Authors:  A R Cox; J F Marriott; K A Wilson; R E Ferner
Journal:  J Clin Pharm Ther       Date:  2004-02       Impact factor: 2.512

Review 3.  The pertussis vaccine controversy in Great Britain, 1974-1986.

Authors:  Jeffrey P Baker
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

4.  Retraction of an interpretation.

Authors:  Simon H Murch; Andrew Anthony; David H Casson; Mohsin Malik; Mark Berelowitz; Amar P Dhillon; Michael A Thomson; Alan Valentine; Susan E Davies; John A Walker-Smith
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

5.  A survey of UK parental attitudes to the MMR vaccine and trust in medical authority.

Authors:  Rachel Casiday; Tricia Cresswell; Deb Wilson; Catherine Panter-Brick
Journal:  Vaccine       Date:  2005-08-08       Impact factor: 3.641

6.  No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder.

Authors:  Yasmin D'Souza; Eric Fombonne; Brian J Ward
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

7.  Why do parents hesitate to vaccinate their children against measles, mumps and rubella?

Authors:  R Alfredsson; E Svensson; B Trollfors; M P Borres
Journal:  Acta Paediatr       Date:  2004-09       Impact factor: 2.299

Review 8.  Patients' role in reporting adverse drug reactions.

Authors:  Kees van Grootheest; Lolkje de Jong-van den Berg
Journal:  Expert Opin Drug Saf       Date:  2004-07       Impact factor: 4.250

9.  Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK.

Authors:  M A Afzal; L C Ozoemena; A O'Hare; K A Kidger; M L Bentley; P D Minor
Journal:  J Med Virol       Date:  2006-05       Impact factor: 2.327

Review 10.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

View more
  2 in total

1.  Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.

Authors:  Hazel J Clothier; Nigel W Crawford; Melissa Russell; Heath Kelly; Jim P Buttery
Journal:  Drug Saf       Date:  2017-06       Impact factor: 5.606

2.  What can we learn from parents about enhancing participation in pharmacovigilance?

Authors:  Janine Arnott; Hannah Hesselgreaves; Anthony J Nunn; Matthew Peak; Munir Pirmohamed; Rosalind L Smyth; Mark A Turner; Bridget Young
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.